Bright Minds Biosciences Inc
CNSX:DRUG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Shareholder Yield
Current shareholder yield for DRUG is .
Dividends, buybacks and debt paydown, as one yield.
Create a free account · No card needed
Create a free account · No card needed
Create a free account · No card needed
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
DRUG Price
Bright Minds Biosciences Inc
| Average Annual Return | 480.87% |
| Standard Deviation of Annual Returns | 1 040.11% |
| Max Drawdown | -94% |
| Market Capitalization | 256.5m CAD |
| Shares Outstanding | 9 860 000 |
| Percentage of Shares Shorted | 0.04% |
DRUG Return Decomposition
Main factors of price return
Stock Splits
DRUG's latest stock split occurred on Jul 14, 2023
The company executed a 1-for-5 stock split, meaning that for every 5 shares held, investors received 1 new share.
Before the split, DRUG traded at 0.8 per share. Afterward, the share price was about 4.48.
The adjusted shares began trading on Jul 14, 2023. This was the only stock split in DRUG's history.